Biotechnology · seed

Avilar Therapeutics

Avilar Therapeutics is a biotechnology company developing extracellular protein degraders to treat disease by removing harmful proteins from the body.

Location
Waltham, Massachusetts, United States
Employees
11-50
People Mapped
13
Industry
Biotechnology

Reporting structure

13 people mapped
  • Joel Barrish
    Joel Barrish
    President & CEO
    Executive
    • Adam Muzikant
      Adam Muzikant
      Chief Business Officer
      Executive
      • Paul Muir
        Paul Muir
        Senior Manager, Strategy and Portfolio Development
    • Effie Tozzo
      Effie Tozzo
      Chief Scientific Officer
      Executive
    • James Kasuboski
      James Kasuboski
      Co-Founder
      Executive
    • Jesse Chen
      Jesse Chen
      Co-Founder and Advisor
      Executive
    • Phil Graham
      Phil Graham
      SVP, Chief Development Officer
      Executive
    • KG
      Karen Goulet
      Executive Assistant

This view shows the leadership structure. 4 more people are mapped in the full chart.

See the full org chart on Crustdata →

About Avilar Therapeutics's team

Avilar Therapeutics is a seed-stage Biotechnology company based in Waltham, Massachusetts, United States with roughly 11-50 employees. Avilar Therapeutics's team spans 1 in data & analytics. Avilar Therapeutics is led by Joel Barrish, President & CEO, alongside James Kasuboski (Co-Founder), Jesse Chen (Co-Founder and Advisor), Adam Muzikant (Chief Business Officer), Effie Tozzo (Chief Scientific Officer), Phil Graham (SVP, Chief Development Officer) and Rene M. Lemieux (Head of Research).

Leadership · 3Data & Analytics · 1

Frequently asked questions about Avilar Therapeutics

What does Avilar Therapeutics do?

Avilar Therapeutics is a seed-stage Biotechnology company based in Waltham, Massachusetts, United States with roughly 11-50 employees. Avilar Therapeutics's team spans 1 in data & analytics. Avilar Therapeutics is led by Joel Barrish, President & CEO, alongside James Kasuboski (Co-Founder), Jesse Chen (Co-Founder and Advisor), Adam Muzikant (Chief Business Officer), Effie Tozzo (Chief Scientific Officer), Phil Graham (SVP, Chief Development Officer) and Rene M. Lemieux (Head of Research).

Who is the CEO of Avilar Therapeutics?

Joel Barrish is the CEO of Avilar Therapeutics, serving as President & CEO. Joel Barrish leads the company and its executive team.

Who is on the leadership team at Avilar Therapeutics?

Avilar Therapeutics's leadership team is led by Joel Barrish (President & CEO) and includes James Kasuboski (Co-Founder), Jesse Chen (Co-Founder and Advisor), Adam Muzikant (Chief Business Officer), Effie Tozzo (Chief Scientific Officer), Phil Graham (SVP, Chief Development Officer), Rene M. Lemieux (Head of Research). Each runs a function within the company.

How is Avilar Therapeutics's team structured?

Avilar Therapeutics's team spans 1 in data & analytics. Each department reports up to the leadership team, as shown in the org chart above.

How big is the data & analytics team at Avilar Therapeutics?

Avilar Therapeutics's data & analytics team has 1 person, making it the largest team at Avilar Therapeutics.

How many employees does Avilar Therapeutics have?

Avilar Therapeutics has 13 employees, of which 1 work in data & analytics.

Where is Avilar Therapeutics headquartered?

Avilar Therapeutics is headquartered in Waltham, Massachusetts, United States.

What funding stage is Avilar Therapeutics at?

Avilar Therapeutics is a seed-stage company operating in Biotechnology.

How do I update or remove a profile on this page?

To correct or remove a profile from Avilar Therapeutics's page, email info@insideorg.com with the name and page link. Verified requests are processed within a few business days.

Reach the team at Avilar Therapeutics

Get the complete team for Avilar Therapeutics with verified work and personal emails, direct phone numbers, plus headcount, funding and growth signals, all through API.

Get the full team on Crustdata →